Arakawa Chemical Industries, Ltd. (TYO:4968)
Japan · Delayed Price · Currency is JPY 1,459.00
-63.00 (-4.14%)
At close: Mar 3, 2026
TYO:4968 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 81,404 | 80,236 | 72,222 | 79,431 | 80,515 | 70,572 | |
Revenue Growth (YoY) | 3.42% | 11.10% | -9.08% | -1.35% | 14.09% | -3.28% |
Cost of Revenue | 64,102 | 63,743 | 60,540 | 67,859 | 62,544 | 53,884 |
Gross Profit | 17,302 | 16,493 | 11,682 | 11,572 | 17,971 | 16,688 |
Selling, General & Admin | 15,429 | 11,956 | 10,936 | 11,082 | 11,132 | 9,813 |
Research & Development | - | 3,058 | 2,965 | 3,024 | 3,100 | 3,247 |
Amortization of Goodwill & Intangibles | - | - | - | - | 76 | 185 |
Operating Expenses | 15,429 | 15,832 | 14,342 | 14,479 | 14,667 | 13,431 |
Operating Income | 1,873 | 661 | -2,660 | -2,907 | 3,304 | 3,257 |
Interest Expense | -463 | -417 | -331 | -224 | -185 | -138 |
Interest & Investment Income | 369 | 341 | 323 | 280 | 257 | 234 |
Earnings From Equity Investments | -305 | - | - | - | - | - |
Currency Exchange Gain (Loss) | 30 | 151 | 172 | 413 | 329 | 21 |
Other Non Operating Income (Expenses) | -201 | 118 | 85 | -250 | -140 | 277 |
EBT Excluding Unusual Items | 1,303 | 854 | -2,411 | -2,688 | 3,565 | 3,651 |
Gain (Loss) on Sale of Investments | 1,139 | 1,268 | 511 | 303 | 3 | 319 |
Gain (Loss) on Sale of Assets | -294 | 745 | -457 | 775 | -279 | -130 |
Asset Writedown | - | - | -7 | -1,838 | -349 | - |
Other Unusual Items | -155 | - | 946 | -1,205 | -1 | 1 |
Pretax Income | 1,993 | 2,867 | -1,418 | -4,653 | 2,939 | 3,841 |
Income Tax Expense | 1,743 | 1,805 | 938 | 883 | 1,132 | 1,460 |
Earnings From Continuing Operations | 250 | 1,062 | -2,356 | -5,536 | 1,807 | 2,381 |
Minority Interest in Earnings | 1,458 | 1,582 | 1,314 | 595 | -305 | -212 |
Net Income | 1,708 | 2,644 | -1,042 | -4,941 | 1,502 | 2,169 |
Net Income to Common | 1,708 | 2,644 | -1,042 | -4,941 | 1,502 | 2,169 |
Net Income Growth | -5.48% | - | - | - | -30.75% | 25.23% |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Change (YoY) | - | - | - | - | - | -2.24% |
EPS (Basic) | 86.09 | 133.27 | -52.52 | -249.06 | 75.71 | 109.33 |
EPS (Diluted) | 86.09 | 133.27 | -52.52 | -249.06 | 75.71 | 109.33 |
EPS Growth | -5.48% | - | - | - | -30.75% | 28.10% |
Free Cash Flow | -1,486 | 712 | -5,611 | -6,621 | -2,160 | -1,740 |
Free Cash Flow Per Share | -74.90 | 35.89 | -282.83 | -333.74 | -108.88 | -87.71 |
Dividend Per Share | 50.000 | 49.000 | 48.000 | 48.000 | 48.000 | 46.000 |
Dividend Growth | 4.17% | 2.08% | - | - | 4.35% | 4.54% |
Gross Margin | 21.25% | 20.56% | 16.18% | 14.57% | 22.32% | 23.65% |
Operating Margin | 2.30% | 0.82% | -3.68% | -3.66% | 4.10% | 4.61% |
Profit Margin | 2.10% | 3.29% | -1.44% | -6.22% | 1.86% | 3.07% |
Free Cash Flow Margin | -1.82% | 0.89% | -7.77% | -8.34% | -2.68% | -2.47% |
EBITDA | 7,562 | 6,777 | 3,191 | 1,570 | 6,500 | 6,422 |
EBITDA Margin | 9.29% | 8.45% | 4.42% | 1.98% | 8.07% | 9.10% |
D&A For EBITDA | 5,689 | 6,116 | 5,851 | 4,477 | 3,196 | 3,165 |
EBIT | 1,873 | 661 | -2,660 | -2,907 | 3,304 | 3,257 |
EBIT Margin | 2.30% | 0.82% | -3.68% | -3.66% | 4.10% | 4.61% |
Effective Tax Rate | 87.46% | 62.96% | - | - | 38.52% | 38.01% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.